. However, programmed cell death is being increasingly understood to benefit the host (for example, by eliminating the intracellular niche of certain pathogens 9 ). Furthermore, the resulting cellular corpses coordinate an appropriate innate immune response to promote the resolution of infection. However, as our understanding of innate immune defences is mainly based on work with pathogens that evade these defences, it is often difficult to recognize how programmed cell death functions in response to infections. Indeed, many discoveries of cell death functions are based on experiments with pathogens that have been genetically modified to remove their normal host-evasion strategies.
Substantial crosstalk exists between different cell death pathways and, as a result, innate immune signalling pathways are well guarded against pathogen attack. The 'guard hypothesis' was first developed from studies on plant immunity, in which it has been shown that innate immune sensors monitor for the perturbation of other innate immune signalling pathways 10 . For example, in Arabidopsis thaliana, pathogens often attempt to inhibit key proteins that are involved in innate immune signalling. When pathogens target one such protein, RPM1-INTERACTING PROTEIN 4 (RIN4), the perturbation is detected by two different nucleotide oligomerization domain (NOD)-like receptors (NLRs), which activate programmed cell death -a phenomenon that is known as the hypersensitive response in plantsto combat the pathogen 11, 12 . This guard mechanism is echoed in mammalian programmed cell death pathways, which function to guard each other, as well as other innate immune signalling pathways.
In this Review, we discuss how the host uses programmed cell death to fight infections with a focus on in vivo studies. We also discuss how difficult, but not impossible, it can be for pathogens to evade programmed cell death owing to the guard functions that are built into the signalling pathways. The roles of pyroptosis, necroptosis and apoptosis during infection are also discussed, as well as how these signalling pathways are functionally interwoven to guard each other. Finally, we discuss the fate of dead cell corpses, such as apoptotic bodies, NETs and pore-induced intracellular traps (PITs), and how their physical properties are beneficial to fighting infections. 
Neutrophil extracellular traps
(NETs). Structures that form after NETosis.
NETosis
Programmed neutrophil death that results in formation of neutrophil extracellular traps (NETs).
Apoptotic bodies
Cellular corpses that form after apoptosis.
Pore-induced intracellular traps
(PITs). Structures that form after pyroptosis and necroptosis to retain organelles and bacteria. pyroptosis 14 , but does not cleave pro-IL-1β or pro-IL-18 on its own. Caspase 11 directly detects lipopolysaccharide (LPS) when it enters the cytosol [15] [16] [17] , and thus protects against infection by cytosol-invasive Gram-negative bacteria, such as Burkholderia thailandensis 18, 19 , but can be evaded by pathogens such as Francisella novicida 15 and Shigella flexneri 20 . Caspases 4, 5 and 11 are often called the non-canonical inflammasome 14 . The role of inflammasomes in pyroptosis has been reviewed in detail 6 and is summarized in FIG. 1 .
Recently, two research groups independently discovered that caspase 1 and caspase 11 cleave gasdermin D, and this cleavage is required to trigger pyroptosis 21, 22 . This finding was later confirmed by a third research . NLRP3 responds to numerous agonists, which may converge upon low cellular potassium concentration, although this remains controversial. NLRP3 will not respond to these agonists unless it also receives a priming stimulus through various Toll-like receptors (TLRs) or from tumour necrosis factor (TNF), which trigger post-translational priming (probably deubiquitylation (De-Ub)), as well as boosting NLRP3 sensitivity by transcriptional induction 163 . AIM2 detects cytosolic DNA 83, 84 , and IFI16, which lacks a clear mouse homologue 167 , also detects viral nucleic acids 50 . Pyrin detects the modulation of Rho family GTPases by bacterial toxins such as Clostridium difficile toxin B (TcdB) 168 . NLRC4 is activated by one of three bacterial flagellin or type III secretion system (T3SS) rod or needle proteins that signal via an upstream NLR in the NAIP family 9, 36, 169, 170 . NLRP1b detects the protease activity of the anthrax lethal toxin 171, 172 . By contrast, caspase 11 is itself the sensor for cytosolic lipopolysaccharide (LPS) [15] [16] [17] . Similar to NLRP3, caspase 11 requires priming, but priming is by either type I interferon or interferon-γ (IFNγ). Either caspase 1 or caspase 11 independently cleaves gasdermin D, from which the released amino-terminal fragment associates with the cell membrane and oligomerizes to form the pyroptotic pore [26] [27] [28] [29] . The cell then swells, resulting in membrane rupture that is known as pyroptosis. In addition, caspase 1 will cleave pro-interleukin-1β (pro-IL-1β) and pro-IL-18 to their mature forms (caspase 11 cannot do this directly) 14 . Mature IL-1β and IL-18 can escape through the gasdermin D pore, or can be released later by membrane rupture 26, 28 . The green and blue arrows represent activation and transcription priming events, respectively. DAMPs, damage-associated molecular patterns; dsRNA, double-stranded RNA; TNFR1, TNF receptor 1. group 23 . Interestingly, the cleavage of gasdermin D was observed a few years earlier, but its importance remained uninvestigated 24 . Gasdermin D is a member of the greater gasdermin-domain protein family, consisting of 6 members in humans and 10 in mice 25 . The function of other gasdermin family members remains to be further elucidated, and although many probably induce pyroptosis 21 , it remains unclear how they are activated. Gasdermins are bipartite proteins the amino-terminal and carboxy-terminal domains of which are connected by a linker, and they have several proposed roles in immune-related diseases 25 . Caspase 1 or caspase 11 cleave this linker of gasdermin D, releasing the N-terminal domain 21, 22 , which then associates with the inner leaflet of the plasma membrane and oligomerizes to form pores. These pores range in size from 10 nm to 33 nm [26] [27] [28] [29] , which is just large enough to allow the passage of mature IL-1β (which is 4.5 nm) 26, 28 ; this could explain how IL-1β can be released from cells that do not lyse, which might hypothetically occur if a very low number of gasdermin D pores form. Small, but detectable, amounts of IL-1β may escape through these pores while small amounts of sodium and water enter. The resulting mild cell swelling should be counteracted by regulatory volume decrease mechanisms, preventing membrane rupture 30 . Later, the cell could remove the pores by normal membrane repair processes 31 . Conversely, if more gasdermin D pores form, considerable swelling should overwhelm the regulatory volume decrease, resulting in membrane rupture that we refer to as pyroptosis, and the release of any remaining processed IL-1β from the cytosol. The N-terminal domain of gasdermin D has affinity not only for the inner leaflet of the plasma membrane, but also for other phospholipids and cardiolipin [26] [27] [28] 32 , which suggests that it may also target organelles. In this regard, the permeabilization of the endoplasmic reticulum may explain the calcium flux that occurs during pyroptosis 33, 34 . Although numerous pathogens trigger pyroptosis in vitro, the role of pyroptosis in vivo is much less well studied. Mice deficient in caspase 1 have an increased susceptibility to a variety of pathogens (see Supplementary information S1 (table) ). The importance of pyroptosis in vivo is primarily inferred from comparing the resistance to infection of Casp1 −/− mice with that of Il1b
Il18
−/− mice. This comparison remains to be made for many pathogens. The recently generated Gsdmd −/− mice are defective for both pyroptosis and the release of IL-1β and IL-18 (at least in vitro) [21] [22] [23] , so a genetic approach to inhibit pyroptosis while maintaining cytokine secretion remains elusive. Finally, it is important to remember that defence against infection may require IL-1β, IL-18 and pyroptosis in conjunction 35 .
Pyroptosis defends against intracellular bacteria. The most direct evidence for pyroptosis in clearing infections comes from the investigation of bacterial strains engineered to activate the NLR family, CARD-containing 4 (NLRC4) inflammasome and induce pyroptosis in vivo. Normally, Salmonella enterica subsp. enterica serovar Typhimurium and Listeria monocytogenes efficiently evade inflammasomes during the systemic phase of infection in mice 9, [36] [37] [38] [39] . By contrast, strains that are engineered to persistently express flagellin are detected by NLRC4 and are rapidly cleared. The observation that mice deficient in IL-1β and IL-18 could still clear these flagellin-engineered bacteria suggests that pyroptosis is the primary mechanism for bacterial clearance 9, [36] [37] [38] . Similarly, caspase 11 provides in vivo defence against S. Typhimurium strains (sifA mutants) that have lost the ability to maintain the integrity of the Salmonellacontaining vacuole and thus aberrantly enter the cytosol 18 . After pyroptosis in vitro, bacteria are damaged 40 , perhaps by gasdermin D pores 28 , and are more susceptible to secondary insults, such as hydrogen peroxide or antibiotics 40 . However, the physiological relevance of this observation remains unclear, as pyroptosis and gasdermin D are insufficient to kill intracellular bacteria in vivo 9 . Instead, after pyroptosis in mice, bacteria are transferred to neutrophils, where they are killed by reactive oxygen species (ROS) 9, 40 . Pyroptosis also protects against non-engineered, opportunistic microorganisms in vivo, including Chromobacterium violaceum, B. thailandensis, Burkholderia pseudomallei and F. novicida 18, 19, 39, 41, 42 . However, additional supporting data are needed to confirm this protection 43 . Among these bacteria, B. thailandensis and C. violaceum have the strongest phenotypes of all tested pathogens in inflammasome-deficient mice 19, 39 (see Supplementary information S1 (table)) 44 . As few as 100 colony-forming units (CFUs) of C. violaceum or B. thailandensis are lethal to inflammasome-deficient mice, whereas wild-type mice survive challenges by 1,000,000 to 20,000,000 CFUs. The strength of these phenotypes leads us to propose that, despite their evasion by host-adapted pathogens, inflammasomes may be maintained over evolutionary time owing to their crucial role in defence against pathogens that are co-evolving with a non-mammalian host that lacks inflammasome defences. Thus, some ubiquitous environmental bacteria have specific virulence traits that are capable of manipulating a generic eukaryotic cell, making them potentially lethal pathogens. However, they are unprepared for the mammalian innate immune system, including inflammasome-driven responses (BOX 1; see further discussion in REF. 44 ).
Additionally, inflammasomes provide defence against microorganisms that have adapted to mammalian hosts. For example, although S. Typhimurium efficiently evades inflammasomes during systemic infection, these bacteria are detected in the gut 45 . Intestinal epithelial cell NLRC4 triggers epithelial cell shedding during infection. Whether this process is a precursor stage during pyroptosis, or is fully independent of pyroptosis, requires further study 45 . Caspase 11 seems to have a similar, parallel role in epithelial shedding to eliminate the low frequency but rapidly replicating subpopulation of S. Typhimurium that aberrantly enter the cytosol . This has been proposed as the major pathway by which HIV depletes CD4 + T cells in vivo 49, 50 . Conversely, IFI16 has also been suggested to have a beneficial role in the defence against HIV infection, although pyroptosis was not examined as a possible mechanism 51 .
RIPK3 triggers necroptosis
Necroptosis, similar to pyroptosis, is a form of programmed lytic cell death. Necroptosis can be triggered by various intricate pathways (discussed below), although perhaps the simplest pathway is through Z-DNA binding protein 1 (ZBP1; also known as DAI and DLM-1).
Induction of necroptosis by ZBP1. ZBP1 binds either Z-DNA or Z-RNA using two Z-DNA-binding motifs, and can respond to DNA viruses, such as MCMV, or to RNA viruses, such as influenza virus [52] [53] [54] . Unlike the normal B-form of DNA, Z-form DNA results from torsional strain that may occur during rapid DNA synthesis that could happen during viral infection. Once activated, its receptor-interacting protein (RIP) homotypic interaction motif (RHIM) binds the RHIM of RIP kinase 3 (RIPK3) 52 . This interaction stimulates RIPK3 kinase activity, auto-phosphorylation and oligomerization [55] [56] [57] , and RIPK3 phosphorylates the necroptosis effector mixed lineage kinase domain-like (MLKL) 58 (FIG. 2) . Following phosphorylation by RIPK3, the MLKL pseudokinase undergoes a conformational switch 59 , licensing interaction with the inner leaflet of the plasma membrane where MLKL oligomerizes to form the necroptotic pore [60] [61] [62] , which is analogous to gasdermin D for pyroptosis. Additional steps may also regulate MLKL 63 . After pore formation, the terminal events in necroptosis are similar to those in pyroptosis; osmotic pressure from ion and water influx results in the rupture of the plasma membrane. In our experiments, pyroptosis and necroptosis (both at 2 hours post-treatment) are morphologically identical in primary macrophages 40 , with the exception of slightly different nuclear morphology (I.J. and E.A.M, unpublished observations). Other research laboratories have visualized differences in RAW264.7 macrophages in settings where pyroptosis is fast (2 hours) while necroptosis is slow (4 hours) 32 . The morphologies in comparison deserve further study. Necroptosis can be investigated in vivo using Ripk3 −/− or Mlkl −/− mice; however, RIPK3 has been suggested to have non-necroptotic functions during influenza virus infection 64 and during inflammatory disease models 65 . Therefore, before attributing a phenotype to necroptosis, it is important to verify that phenotypes observed in Ripk3 −/− mice are also seen in Mlkl −/− mice.
Necroptosis defends against viral infections. The clearest phenotypes for necroptosis during in vivo infection highlight an antiviral role. MCMV encodes a viral

Box 1 | Hypothesis to explain the importance of inflammasomes despite evasion by pathogens
In Lewis Carroll's Through the Looking-Glass, and What Alice Found There
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, Alice finds herself in a race with the Red Queen, in which "it takes all the running you can do, to keep in the same place." This inspired the evolutionary hypothesis that constant change is required to survive within a constantly changing environmental niche alongside constantly changing competitors. But in the end, each organism tends to maintain its place within the niche. This concept applies to the host-pathogen interaction: as hosts (analogously to Alice) evolve new immune responses, pathogens (analogously to the Red Queen) evolve virulence factors to overcome them. For example, numerous pathogens evade inflammasome detection . Thus, many successful pathogens seem to be perpetually one step ahead in the evolutionary equilibrium between inflammasome detection and evasion. Conversely, aberrant inflammasome activation can be lethal 15, 16, 34 , which might select for the loss of these sensors over time. One must ask, then, why would 'Alice' run with inflammasomes that fail to fight the 'Red Queen'?
Interestingly, there are two pathogens that inflammasomes decisively control in vivo: Burkholderia thailandensis 19 and Chromobacterium violaceum 39 (see Supplementary information S1 (table)) 44 . Both use substantial virulence traits that make them lethal to inflammasome-deficient mice and immunocompromised humans. However, in healthy animals, inflammasomes render them harmless. B. thailandensis and C. violaceum are ubiquitous soil and mud bacteria the natural host of which remains unknown; perhaps it is a lower eukaryote that lacks inflammasomes, such as insects or nematodes.
This leads us to propose a corollary to the Red Queen hypothesis. We propose that C. violaceum and B. thailandensis are not running an evolutionary race alongside humans because they are not natural human pathogens. Instead, they run a completely separate race altogether, alongside a non-human host. They may occasionally lose their way and clumsily 'stumble' onto the human 'racecourse', where they find themselves brushed aside by inflammasomes. Hence, the mammalian innate immune response is perpetually winning the evolutionary race against environmental pathogens that may be dangerous but that lack sophisticated immune evasion strategies.
This confluence of races could explain why inflammasomes are maintained over evolutionary time despite the prevalence of evasive pathogens. Inflammasomes may act as a barrier to prevent opportunistic infection. Such a barrier may not be perfect, as B. thailandensis has two close relatives that have advanced on to the pathway to mammalian pathogenesisenvironmental bacteria that have evolved into Red Queens. Burkholderia pseudomallei is broadly pathogenic to mammals and causes melioidosis 158 . Further along the adaptation course is Burkholderia mallei, which is the highly virulent equine-adapted cause of glanders 159 . Further caveats to this hypothesis are described in REF. 44 . Our hypothesis thus predicts that certain innate immune sensors provide a near-permanent victory for the host in defence against a large reservoir of potentially deadly environmental pathogens, while host-adapted pathogens must evade these sensors. inhibitor of RIP activation (vIRA), the RHIM domain mimic of which inhibits RIPK3 signalling, and thereby prevents necroptosis 52 . A RHIM domain mutant virus is attenuated, but this attenuation is reversed in Ripk3
and Zbp1 −/− mice 52 . Similarly, human-adapted herpes simplex virus 1 (HSV-1) and HSV-2 express two protein homologues, ICP6 and ICP10, that inhibit human RIPK3 (REFS 66,67). However, there seems to be some degree of species tropism; human HSV-1 ICP6 interacts with mouse RIPK3, presumably attempting to inhibit it, but owing to the species mismatch, RIPK3 is activated, which triggers necroptosis to prevent viral replication [66] [67] [68] . Accordingly, Ripk3 −/− mice are susceptible to HSV-1 infection 69 . This idea does not hold true for MCMV, which inhibits necroptosis in both human and mouse cells 66 . Figure 2 | Apoptosis and necroptosis. Apoptosis can be triggered through intrinsic or extrinsic pathways, including by natural killer (NK) cells and cytotoxic T lymphocyte granzymes. These stimulate the cleavage of BID to tBID, which causes BAX and/or BAK to trigger mitochondrial outer-membrane permeabilization (MOMP), resulting in the release of cytochrome c, which binds to apoptotic protease activating factor 1 (APAF1) (not shown). APAF1 then oligomerizes into the apoptosome, the platform for caspase 9 activation. Either caspase 8 or caspase 9 will cleave the effector caspases caspase 3 and caspase 7 into their active forms, which leads to apoptosis 2 . Necroptosis can be triggered by Z-DNA or Z-RNA sensing via Z-DNA binding protein 1 (ZBP1) 52 , which activates receptor-interacting protein kinase 3 (RIPK3) followed by the phosphorylation of mixed lineage kinase domain-like (MLKL). Phosphorylated MLKL binds to the inner leaflet of the plasma membrane and forms the necroptotic pore [60] [61] [62] . In the more complex necroptotic pathway, tumour necrosis factor receptor 1 (TNFR1), Toll-like receptor 3 (TLR3)-TRIF and TLR4-TRIF signal via RIPK1 to activate NF-κB (not shown), but RIPK1 is not required for the TRIF-type I IFN response 97, 98 . RIPK1 can be thought of as a finely balanced see-saw with two guards: caspase 8 on one side, which is balanced by a duo of RIPK3 and ZBP1 on the other side. When TNFR1-TLR3-TLR4 signalling proceeds normally, RIPK1 is 'balanced' and functions as a scaffolding protein that becomes polyubiquitylated, and serves as a platform for signalling complex assembly 5 that drives transcriptional responses. When signalling is inhibited, for example, by the inhibition of cIAP1/2 pharmacological inhibitors (with SMAC mimetics), by the inhibition of TAK1, by the inhibition of protein synthesis, by blocking RIPK1 ubiquitylation 3 , or potentially by virulence factors, RIPK1 becomes 'unbalanced'. RIPK1 then recruits FAS-associated death domain (FADD; a DD-DED (death effector domain)) via DD-DD interactions, and FADD recruits caspase 8 via DED-DED interactions, thereby triggering extrinsic apoptosis [173] [174] [175] . Successful caspase 8 activation provides negative feedback to prevent necroptosis by cleaving RIPK1 and RIPK3 in the kinase domains 176, 177 . However, the inhibition of caspase 8 pharmacologically or through viral virulence factors permits continued RIPK1 kinase activity, and the see-saw tips in the other direction. RIPK1 recruits RIPK3 via RHIM-RHIM interaction, and phosphorylates it, triggering RIPK3 kinase activity and necroptosis [178] [179] [180] . Thus, RIPK1, RIPK3 and caspase 8 act as a cross-guard system for TNFR1, TLR3 and TLR4. TLRs such as TLR2 do not signal through TRIF 76, 100, 108, 114 , unless longer time points are examined 75 , during which TLR2-driven TNF could require caspase 8 to cause paracrine TNFR1 stimulation. DAMPs, damage-associated molecular patterns; dsRNA, double-stranded RNA; ER, endoplasmic reticulum.
The antiviral role for necroptosis is further supported by the observation that Ripk3 −/− mice are susceptible to vaccinia virus infection 56 . The RIPK3 pathway also defends against a mouse-adapted influenza virus infection. Zbp1 −/− and Ripk3 −/− mice have increased mortality during infection with the PR8 strain of influenza A virus 54, 64 . However, the susceptibility of Ripk3 −/− mice to influenza virus was not replicated in another study 70 , and a third study showed the reverse, with Zbp1 −/− mice having higher viral titres but reduced tissue damage and mortality 53 , suggesting a simultaneously beneficial role in defence paired with a detrimental role in immunopathology.
Finally 77 , but Ripk3 −/− mice are paradoxically resistant to both skin infection and lung infection 77, 78 . Inhibitor treatment suggests that necroptosis may be pathological during Serratia marcescens infection 79 , but this needs further study using knockout mice. Specific inhibition of RIPK3 by bacteria has not yet been described. Many more bacterial infection models remain to be examined in Ripk3 −/− and/or in Mlkl −/− mice, and it seems likely that some studies will establish a role for necroptosis in defence against specific bacteria.
Apoptosis during infections
Apoptosis is a form of programmed cell death that is characterized by cytoplasmic shrinking, cell rounding, chromatin condensation, DNA fragmentation and membrane blebbing 1, 2 . Apoptosis can be initiated by cell extrinsic pathways (which are mediated by death receptors) and cell intrinsic (mitochondrial) pathways, both of which culminate in the activation of the effector caspases 3, 6 and 7 (FIG. 2) . Apoptosis can also be initiated by cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells that deliver granzymes, which activate apoptotic caspases. Upon completion of apoptosis, cellular contents are encapsulated within membrane-bound apoptotic bodies. If these bodies are not cleared, they will undergo secondary necrosis (rupture), releasing cytosolic damage-associated molecular patterns (DAMPs) to the extracellular space 80 . The role of apoptosis against infection is perhaps best appreciated by inference, as numerous viruses and bacteria encode apoptosis inhibitors that are essential for virulence (reviewed in REFS 81, 82) . This also raises the conundrum: if most viruses evade apoptosis, do pathogens exist that apoptosis effectively counters, providing fully penetrant innate immunity
? We focus below on some of the recent advances in apoptosis research that are relevant to infection.
Guarding cell intrinsic apoptosis with interferons.
Intrinsic apoptosis is often driven by cell intrinsic stresses, such as DNA damage and growth factor withdrawal, which leads to mitochondrial outer-membrane permeabilization (MOMP) 83, 84 . Although its structure remains to be fully elucidated, the MOMP pore appears to be formed by BAX and BAK 83, 84 . MOMP leads to the release of mitochondrial contents, including cytochrome c, into the cytosol where it binds to the NLR protein apoptotic protease activating factor 1 (APAF1), which oligomerizes into a hub to form the apoptosome -an activating platform for the initiator caspase 9. Activated caspase 9 in turn cleaves and activates the effector caspases caspase 3 and caspase 7 (REF. 2). As apoptosis destroys the replicative niche of intracellular pathogens, particularly viruses, those that prevent apoptosis will replicate better as the infected cell lives longer.
Historically, apoptosis is considered immunologically silent owing to the collective efforts of caspases. For example, apoptotic DAMPs that can induce a robust type I interferon-mediated pro-inflammatory response are dampened by caspases 85, 86 . During viral infection of Casp9 −/− or Casp3 −/− Casp7 −/− cells, MOMP is initiated, but apoptosis fails to proceed. MOMP eventually releases mitochondrial DNA (mtDNA) into the cytosol, where it is detected by the DNA sensor cGAS, resulting in a type I IFN response 85, 86 . Thus, pathogens that only block caspases will encounter a cGAS-driven type I IFN response that effectively guards events downstream of MOMP. This interferon response promotes resistance to viral infections, including encephalomyocarditis virus (EMCV) and vesicular stomatitis virus (VSV). By contrast, blockade upstream of MOMP -which can be studied in Bax −/− Bak −/− mice -does not trigger cGAS because MOMP is not initiated and mitochondria retain their DNA 85, 86 .
Apoptosis and necroptosis guard innate immune signalling. Cell extrinsic apoptosis is typically initiated by extracellular stress signals that engage a subset of the tumour necrosis factor (TNF) superfamily of receptors known as death receptors 2 . Prototypical extrinsic stimuli include FasL, TNF and TNF-related apoptosisinducing ligand (TRAIL). Following death receptor engagement, caspase 8 is recruited and activated via the death inducing signalling complex (DISC). In certain cell types, caspase 8 can also cleave BID into tBID, initiating MOMP in a positive feedback loop that leads to the activation of caspase 9, another initiator caspase, thus ensuring a strong initiation of apoptosis. Therefore, caspase 8 activation connects extrinsic and intrinsic apoptosis (FIG. 2) .
Additionally, caspase 8 is ensconced within the TNF receptor 1 (TNFR1), TLR3 and TLR4 signalling pathways [3] [4] [5] 87 . Caspase 8 interacts with RIPK1, which is a key scaffolding protein within the signalling cascade [3] [4] [5] 87 . Thus, caspase 8 is often interpreted as a node that regulates the divergence of signalling towards either transcriptional responses or apoptosis. For example, it is frequently stated that caspase 8 regulates TNFdependent transcriptional responses and TNF-driven apoptosis [3] [4] [5] 87 . Below, we present this pathway from the perspective of a pathogen.
TNFR1, TLR3 and TLR4 are important innate immune sensors -which respond to TNF, doublestranded RNA and LPS, respectively -that drive potent transcriptional responses (but that do not trigger cell death under normal circumstances) 3 . Hence, these sensors are attractive targets for pathogens to inhibit, particularly as all three use RIPK1 as a scaffolding node to assemble signalling complexes (FIG. 2) . However, when signalling at or downstream of RIPK1 is pharmacologically inhibited, this causes an alteration in the flow of signals through the pathway, which triggers a counter response that activates caspase 8 (REFS 3, 5) . In other words, if pathogens target these signalling pathways they would be met by a caspase 8 'tripwire' that triggers apoptosis. If pathogens possessed virulence strategies to simultaneously target RIPK1 and caspase 8, they would encounter a second tripwire in RIPK3, which also interacts with RIPK1. As the first caspase 8 tripwire fails to function, signalling build-up at RIPK1 results in the activation of RIPK3, triggering this second guard pathway that drives the response to infection to necroptosis rather than to apoptosis (FIG. 2) . Thus, caspase 8, RIPK1 and RIPK3 essentially function as a triangular guard system. This cross-guarded system becomes activated during embryogenesis in Casp8 −/− mice, causing embryonic lethality 4 . In line with the cross-guard model, Casp8 −/− lethality is rescued by simultaneous deletion of Ripk3 (REFS 88, 89) . Thus, caspase 8 is guarded by RIPK1-RIPK3-driven necroptosis.
Further, recent evidence suggests that RIPK3 is guarded by caspase 8, essentially reverse guarding the guard. Although Ripk3 −/− mice are viable and healthy, mice engineered to carry some (but not all) point mutations within the Ripk3 kinase enzymatic site suffer from neonatal lethality as a caspase 8 guard programme becomes activated, triggering lethal apoptosis during development 90, 91 . In this guard system, the RIPK3 protein must be present and abnormal in order to trigger caspase 8, whereas simple absence of RIPK3 does not trip this guard pathway (as it does when caspase 8 is absent 95, 96 . Once activated, ZBP1 activates RIPK3. Together, they essentially double guard RIPK1. To add to the complexity, the caspase 8 guard function is built into the RIPK1 scaffold function; TNFR1-TLR3-TLR4 signalling fails to drive transcription in Casp8 −/− cells 97, 98 . It seems that RIPK1 fails to function when it is unable to interact with its guard caspase 8. The same may be true for Ripk3 −/− cells but only in specific cell types 99 . By contrast, TLR2 signalling, which does not use TRIF-RIPK1, remains intact 76,100 (although one study did see defects in TLR2 signalling 75 , perhaps owing to autocrine TNF signalling FIG. 2 
)).
One way to try to study cell extrinsic apoptosis in vivo is to compare Casp8
Ripk3
−/− mice with Ripk3 −/− control mice. However, given the compound effects of deleting Casp8 (elaborated in BOX 2), it is not surprising that Casp8
−/− mice are highly susceptible to multiple infectious challenges. Casp8
−/− mice have more rapid dissemination and/or lethality of fully virulent Y. pestis or Y. pseudotuberculosis 74, 76 . These mice also have higher stool burdens during C. rodentium infection 75 . Furthermore, they succumb to infections by Y. pestis strains engineered to enhance TLR4 detection 76 , perhaps
Box 2 | Compound defects in Casp8
−/− mice Investigators generated mice lacking caspase 8 to study cell extrinsic apoptosis in vivo, but these mice turned out not to be viable 4 . A caspase 8 deletion induces necroptosis and the destruction of the yolk sac vasculature, and this circulatory failure leads to embryonic death. However, the introduction of Ripk3 −/− complements the lethality, and Casp8
−/−
Ripk3
−/− mice are viable as cells in these mice cannot undergo necroptosis 88, 89 .
Comparing Casp8
−/−
Ripk3
−/− mice with Ripk3 −/− controls allows the study of caspase 8 genetic deficiency in vivo. However, these mice must be interpreted with great caution because the Casp8 −/− mutation eliminates multiple signalling pathways: first, it eliminates extrinsic apoptosis driven by tumour necrosis factor (TNF), Fas and TNF-related apoptosis-inducing ligand (TRAIL), which could be beneficial during infection 88, 89, 160 ; second, it alters homeostasis in adaptive immune cells, resulting in a lymphoproliferative disorder that is apparent at 2 months of age 88, 89 ; third, it substantially impedes or fully abrogates transcriptional responses via TNF receptor 1 (TNFR1), Toll-like receptor 3 (TLR3) and TLR4 owing to loss of the caspase 8-RIPK1 scaffolding platform 97, 98 ; fourth, its effect on TNF, TLR3 and TLR4 also prevents these receptors from post-translational priming of the NLR family, pyrin domain-containing 3 (NLRP3) inflammasome 75 BOX 2) ) have increased mortality due to influenza A virus infection 64 , perhaps owing to defects in TLR3 signalling. In summary, multiple innate immune defence pathways intersect at the caspase 8-RIPK1-RIPK3 triangle. It seems likely that the intricate cross-wiring of these pathways has an important role in preventing pathogens from inhibiting the function of TLR3, TLR4, TNFR1, extrinsic apoptosis and necroptosis.
Neutrophil NETosis makes NETs
Whereas necroptosis and apoptosis are seen in many cell types, another form of cell death is uniquely observed in neutrophils -NETosis, which primarily functions to extrude NETs 101 (FIG. 3) . NETosis is triggered either by various microbial and sterile activators -a process that has recently been shown to differentiate between microorganisms based on their size 102 -or by the ligation of specific receptors, including complement, antibodies, cytokines and TLRs
103
. During NETosis, ROS-dependent release of elastase and myeloperoxidase from neutrophil granules to the nucleus (although not under all conditions) 104 promotes histone degradation and chromatin decondensation 105 . The effects of ROS and proteases on the nuclear material leads to the extrusion of a meshwork of chromatin fibres, dotted with granules that contain antimicrobial molecules, which traps and kills extracellular bacteria and fungi.
NETosis is accompanied by ruptures in the plasma membrane and neutrophil lysis 101 . However, a mounting body of evidence has demonstrated that neutrophils can release NETs while maintaining an intact plasma membrane 103 ; this is paradoxically referred to as 'vital NETosis' , in contrast to the typical 'suicidal NETosis' . After vital NETosis, neutrophils continue to function in chemotaxis, phagocytosis and bacterial killing 106 .
Whether a neutrophil undergoes suicidal or vital NETosis seems to be dependent on the NET-inducing stimulus. It is unknown how NETs are extruded from neutrophils without lysing the cell. Whether NETosis has antimicrobial functions that are independent of NET extrusion remains unknown, but one could imagine that pathogens within neutrophils during NETosis could be killed by the release of granule contents into the nucleus or cytosol (see REF. 7 for a comprehensive review on NET signalling mechanisms). How NETs combat infection is described further below in our discussion of the consequences of cell death.
Crosstalk between cell death pathways There are many cross-pathway signalling events among apoptosis, necroptosis and pyroptosis (FIG. 4) . Most prominent among these are NLR family, pyrin domaincontaining 3 (NLRP3) interactions with the different cell death pathways. Although the precise signal detected by NLRP3 is uncertain, NLRP3 can be considered as the 'sensor for cellular catastrophe' (BOX 3) that is activated when normal cellular physiology breaks down.
Role of caspase 8 upstream of inflammasome signalling.
Caspase 8 is a component of the TNFR1-TLR3-TLR4 signalling scaffold. Therefore, loss of caspase 8 prevents these receptors from providing both post-translational and transcriptional priming of inflammasome components. For example, pro-IL-1β and NLRP3 transcriptional induction is compromised in Casp8-deficient cells 75, 76, 100, [107] [108] [109] , although this may not hold true for all cell types 110 . Furthermore, NLRP3 requires TNFR1 or TLR signalling to provide post-translational priming [111] [112] [113] .
Thus, Casp8
−/− cells fail to prime NLRP3 after TNFR1, TLR3 or TLR4 stimulation but can prime NLRP3 within 10 minutes of TLR2 stimulation 76, 100, 108, 114 . However, when longer time points (4 hours) are examined, TLR2-driven TNF may require caspase 8 to cause paracrine stimulation 75 . By contrast, Casp8 deficiency does not prevent the The fate of the cell corpse is dependent on the cell death pathway. Extrinsic apoptosis and intrinsic apoptosis lead to the formation of apoptotic bodies that are engulfed by a secondary phagocyte, a process that is referred to as efferocytosis. In the absence of efferocytosis, apoptotic bodies can undergo secondary necrosis. Lytic death of cells infected with an intracellular pathogen, including pyroptosis, leads to the formation of a pore-induced intracellular trap (PIT), which traps the pathogen within the cell corpse. The PIT also presents ligands that are recognized by neutrophils (and potentially macrophages), which efferocytose the PITs and associated bacteria, ultimately killing the pathogen. Efferocytosis of pathogen-containing apoptotic bodies also eliminates the pathogen. Necroptosis and necrosis also result in PITs in vitro, although the physiological importance in vivo needs further study. Following the detection of extracellular pathogens, neutrophils extrude a meshwork of chromatin dotted with granules loaded with antimicrobial molecules. These neutrophil extracellular traps (NETs) trap and kill extracellular pathogens. activation of inflammasomes that do not need priming, such as NLRC4 (REFS 75, 107) . The in vivo relevance of these interactions remains to be assessed.
Caspase 8 downstream of inflammasomes ensures death.
Caspase 8 can also function downstream of inflammasomes, which makes caspase 8 interactions more complicated. Caspase 8 may guard pyroptosis, and thereby ensure the activation of cell death in a hypothetical situation in which a pathogen attempts to inhibit pyroptosis. ASC is a small adaptor protein between most inflammasomes and caspase 1; the ASC pyrin domain (PYD) interacts with the PYD of inflammasomes, and its caspase activation and recruitment domain (CARD) interacts with the CARD of caspase 1 (REF. 13 ). Upon activation by inflammasomes, ASC polymerizes to provide a large surface area of activating CARD domains 115, 116 . In the absence of caspase 1, cell death still occurs after ASC polymerization, but under slower kinetics and with apoptotic morphology. In this case, caspase 8 is proposed to interact with ASC through an unusual heterotypic death domain fold interaction between the ASC CARD and the caspase 8 death effector domain [117] [118] [119] (FIG. 4) . This pathway may be most relevant when a pathogen directly inhibits caspase 1 without preventing ASC polymerization 120 . This situation is mimicked by comparing Asc −/− mice with Casp1 −/− mice, which reveals an in vivo effect of cytokine responses through this pathway during an F. novicida infection 117, 121 , but this has no effect on the F. novicida bacterial load 117, 121 .
In addition, caspase 8 may be directly activated by caspase 1 in settings in which gasdermin D is absent. Although cell death was fully ablated in Gsdmd −/− cells in one study 21 , a slower form of cell death was observed in another study 22 that was later suggested to be apoptosis that was associated with caspase 8 activation 23 . By contrast, this pathway to apoptosis was not observed after the activation of caspase 11 (REF. 22) (FIG. 4) . Some researchers describe this pathway as the "suppression of apoptosis by pyroptosis" (REF. 23) or as a "balance between pyroptosis and apoptosis" that depends on the quantity of Figure 4 | Interactions among apoptotic, necroptotic and pyroptotic pathways. Cell death pathways can interact with each other, with the caveat that once a cell death pathway runs to completion, the interaction ends. The exception to this is the lysis of apoptotic bodies by secondary necrosis, which releases cytosolic contents, effectively converting apoptosis to lytic cell death. Signalling pathways running through RIPK1 will fail if Casp8 is deleted, affecting the priming of NOD-, LRR-and pyrin domain-containing 3 (NLRP3) and caspase 11 (REFS 75, 76, 100, (107) (108) (109) . Caspase 1-driven interleukin-18 (IL-18) can have two interactions with other pathways: first, by inducing interferon-γ (IFNγ) production to prime caspase 11 (REF. 19 ); and second, by stimulating natural killer (NK) cytotoxic activity 39 . The terminal events occurring after the mixed lineage kinase domain-like (MLKL) or gasdermin D pores open are catastrophic, resulting in the loss of cellular potassium, which is the trigger for NLRP3 activation 164, 165 . In the window between potassium loss and membrane rupture, NLRP3 activity will trigger caspase 1-dependent processing of IL-1β and IL-18 processing. Finally, ASC and caspase 1 can activate caspase 8, triggering apoptosis 22, 23, 117, 118 . Grey arrows indicate interacting pathways. DAMPs, damage-associated molecular patterns; De-Ub, deubiquitylation; FADD, FAS-associated death domain; TNF, tumour necrosis factor. agonist 118 . However, we prefer the interpretation that this is a versatile pathway that can switch from pyroptosis to apoptosis in the hypothetical case in which a pathogen inhibits pyroptosis, thus ensuring cell death 117 . Apoptosis could thus be considered as a backup guard pathway for pyroptosis, however, the in vivo relevance it may have in the control of pathogen burden remains to be elucidated.
Finally, caspase 8 has been proposed to substitute for caspase 1 as a pro-IL-1β and pro-IL-18 cleaving enzyme [121] [122] [123] [124] [125] , although this function warrants further study.
In summary, caspase 8 has been proposed to function upstream of inflammasomes, but also downstream of inflammasomes, which creates a fairly confusing picture when one attempts to integrate the multiple functions of caspase 8 into a single model. In vivo validation of these interactions will hopefully reveal their physiological importance.
Caspase 1-driven IL-18 primes caspase 11. Mouse caspase 11 activation is strictly dependent on priming; in vitro, this is commonly accomplished by studying cells that have previously been primed by type I IFNs (through TLR3-or TLR4-driven type I IFN secretion) 6 or by TLR2 stimulation 16 . The TLR3 pathway has been used in vivo to enable caspase 11 priming during LPS shock models 15, 16 . Surprisingly, these pathways were insufficient to prime caspase 11 during infection with the cytosol-invasive bacterium B. thailandensis in vivo 19 . Instead, NLRC4-driven caspase 1 activation was required to drive IL-18 production, which in turn stimulated IFNγ within the first day of infection. IFNγ was absolutely essential for caspase 11 priming in this model, and endogenous TLR agonists and type I IFN were insufficient. The IL-18 requirement could be bypassed only under delayed kinetics after 3 days as alternative mediators eventually promoted IFNγ production 19 . Thus, in the context of intracellular bacterial infection in vivo, caspase 1 acts upstream of caspase 11 priming, which was surprising as NLRP3 and caspase 1 are commonly thought to function downstream of caspase 11
IL-18 drives NK cytotoxicity versus intracellular bacteria. NK-derived IFNγ has been well established to combat intracellular bacterial infection. However, whereas NK cytotoxicity is crucial for combating viruses such as MCMV, HSV-1 and influenza virus, as well as cancer, initial in vitro studies suggesting that bacterially infected cells are killed by NK cells have been uniformly disproved by subsequent in vivo studies 126, 127 . Collectively, these data led to the conclusion that cytokines rather than cytotoxicity are the primary mode of NK cell-mediated protection against intracellular pathogens. However, our group recently showed that NK lysis of infected hepatocytes is crucial for controlling infection by an intracellular bacterial pathogen 39 . In this model, infected phagocytes detected C. violaceum via NLRC4, which led to the production of IL-18 and the activation of liver NK cells. Activated NK cells then directly lysed infected hepatocytes in a perforin-dependent manner. NK cytotoxicity also controlled the inflammasome-evasive L. monocyto genes infection, but only when mice were treated with exo genous IL-18 (REF. 39 ). This example highlights the importance of direct cytotoxicity against bacteria and crosstalk between two different cell death modalities -inflammasomes and apoptosis -to efficiently fight infection. Similarly, NK cytotoxicity that was initiated by inflammasome detection of S. Typhimurium in a colitis model was recently shown to promote inflammation 128 , and Prf1 −/− mice were also susceptible to C. rodentium during the innate phase of infection 129 . Interestingly, human (but not mouse) NK cells have additional means to directly kill bacteria, as granulysin delivered on NK degranulation is directly toxic for both bacteria and parasites 130, 131 .
How programmed cell death clears infection
Recent studies have examined the fate of pathogens after apoptosis, necroptosis and pyroptosis, and how these cell death mechanisms promote the resolution of infection. Apoptosis converts cells into apoptotic bodies, which release a series of find-me and eat-me signals that promote efferocytosis, which is the phagocytosis of dead cells. How the necroptotic and pyroptotic cells are Although NLR family, pyrin domain-containing 3 (NLRP3) is the most extensively investigated inflammasome, it remains the most enigmatic. NLRP3 is activated in response to numerous insults, including pore-forming toxins, ionophores and phagocytosis of indigestible particulates. As such, NLRP3 detects catastrophic events, including the inability to maintain cytosolic potassium concentration 162 through an unknown biochemical mechanism. Besides loss of cytosolic potassium, other mechanisms have also been proposed to explain NLRP3 activation, including endoplasmic reticulum (ER) stress and mitochondrial dysfunction 163 . NLRP3 is also activated downstream of lipopolysaccharide (LPS) detection by caspase 11 (REF. 14) . When caspase 11 cleaves gasdermin D, it polymerizes into the pyroptotic pore. The resulting loss of cytosolic potassium triggers NLRP3 and consequent interleukin-1β (IL-1β) and IL-18 processing 164, 165 (FIG. 3) . Thus, NLRP3 has a very short activation window before cellular swelling causes the rupture of the plasma membrane. IL-1β secretion downstream of cytosolic LPS is thus much lower than other direct inflammasome agonists. Currently, there is no in vivo evidence supporting the physiological relevance of NLRP3 activation downstream of caspase 11. In fact, caspase 11-dependent defence against Burkholderia thailandensis does not require NLRP3 (REF. 19 ), which argues against an in vivo role, at least in this model system.
Similarly, NLRP3 activation downstream of necroptosis 53,100,110 may be caused by the same mechanism. It is likely that potassium loss after opening of the mixed lineage kinase domain-like (MLKL) pore is detected by NLRP3. This pathway may promote IL-1β secretion in vivo during influenza virus and vesicular stomatitis virus infection 166 , but more work is needed to determine whether MLKL is the primary pathway through which NLRP3 is activated in vivo, or whether NLRP3 is actually responding to some other catastrophic event during infection in vivo.
cleared is currently under thorough investigation. These mechan isms remove the niche for intracellular viruses and bacteria, but pathogens frequently survive host cell death. Finally, NETosis generates structures that are specifically microbicidal. We discuss below what happens to pathogens after programmed cell death (FIG. 3) .
Efferocytosis of apoptotic bodies. The resolution phase of apoptosis is another example of how apoptotic caspases maintain immunological silence. Failure to clear apoptotic debris can contribute to inflammatory disease or autoimmune disease 80 . During normal development and homeostasis, apoptotic bodies are efferocytosed by a secondary phagocyte, thereby preventing secondary necrosis and maintaining immunological quiescence 80 . Efferocytosis is currently an active area of research in the context of infection.
Until recently, apoptosis was often considered intrinsically bactericidal. For example, apoptosis was thought to kill Mycobacteria spp. in vitro 132 and in vivo 133 . However, recent studies have suggested that Mycobacterium tuberculosis and Mycobacterium marinum survive apoptosis but are subsequently killed after efferocytosis by a secondary macrophage 134, 135 . This efferocytic phagosome matures, acidifies and kills the bacteria using ROS. Notably, pathogens that resist apoptosis, such as Mycobacterium spp., also interfere with efferocytosis, which increases their survival 136 . L. monocytogenes, conversely, exploits efferocytosis receptors in order to spread from cell to cell 137 . The Listeriolysin O toxin damages the plasma membrane, exposing phosphatidyl serine, which is recognized by TIM4. As L. monocytogenes propels itself with actin comets, TIM4 on the neighbouring cell promotes efferocytosis of the protruding membrane, enabling L. monocytogenes to enter the next cell 137 . Virus-containing apoptotic bodies can also be efferocytosed; for example, influenza A virus induces the apoptosis of infected epithelial cells, and neighbouring macrophages efferocytose apoptotic bodies that contain viral progeny, which reduces viral titres 138 . However, some viruses use mimicry to induce apoptosis in order to spread to neighbouring cells 139 .
NETs trap extracellular microorganisms. In addition to killing pathogens after phagocytosis, neutrophils can target extracellular pathogens using NETs 101 . NETs have two distinct antimicrobial roles by trapping and killing pathogens. Extensive intravital and confocal microscopy of neutrophils in infected tissue show in real time how bacterial and fungal pathogens can be trapped in NETs 103, 105, 140 . Moreover, additional pathogens are trapped in the extracellular chromatin in vitro. In fact, systemic DNase treatment in a mouse model of an S. aureus skin infection, which induces NET formation, resulted in the escape of the bacteria from the site of inoculation and increased vascular bacterial loads 106 . The extent to which NETs are directly capable of killing bacterial and fungal pathogens remains controversial, as not all bacterial pathogens trapped in NETs are killed and there are no known specific inhibitors that unlink NET release from NET antimicrobial activity. , evade NETs by incorporating NET-associated DNA into their biofilms, which promotes their replication in vivo. Hence, the trapping of some microorganisms by NETs in the absence of bacterial killing could be advantageous to the pathogen. Finally, some pathogens evade killing through NETs by sidestepping the specific antimicrobial activity of NET components by expressing polysaccharide capsules 153, 154 . A full overview of exotoxins that disrupt NETs and other evasion mechanisms is provided elsewhere 155 .
Pore-induced intracellular traps. Recent evidence from our group establishes the fate of the pyroptotic cell corpse and its role in coordinating a downstream innate immune response. Similar to apoptosis, pyroptosis does not kill bacteria 9, 40 . We initially assumed that pyroptosis released intracellular bacteria to the extracellular space 9 . However, in a follow-up study we show that viable bacteria remain trapped within the cellular debris of pyroptotic macrophages 40 . This trapping seems to be mediated by the pyroptotic cell membrane, which remains mostly intact despite containing discrete ruptures, encompassing collapsed organelles and cellular structures. We call this structure the pore-induced intracellular trap (PIT) 35, 40 ( FIG. 3) , which is conceptually parallel to NETs. Both PITs and NETs trap the pathogen and prevent microbial dissemination. In contrast to NETs, which act against extracellular microorganisms, PITs trap intracellular microorganisms. In addition to pyroptosis, necroptosis and necrosis also result in the formation of a PIT that is efferocytosed by neutrophils and macrophages 40 , although the in vivo relevance of necroptotic and necrotic PITs in the context of infection remains to be elucidated.
PITs coordinate innate immune responses to combat intracellular bacteria; PIT formation leads to complement activation, the release of IL-1β and IL-18, and eicosanoid production. These mediators recruit neutrophils, which use phagocytic scavenger and complement receptors to efferocytose the PIT and entrapped bacteria 35, 40 , which is conceptually parallel to the efferocytosis of bac teria trapped within apoptotic bodies 134 . Ultimately, this secondary phagocyte kills the bacteria via ROS 40 . Therefore, we propose that PITs are highly effective, immunologically important structures with two key functions; PITs immobilize the pathogen to prevent dissemination and to promote efferocytosis by a secondary phagocyte that kills the pathogen.
Concluding remarks
Much work remains to be done to fully understand how pyroptosis, necroptosis, apoptosis and NETosis defend against infection in vivo. Genetic tools to study programmed cell death in vivo remain confounded by effects on other aspects of host defence. For example, Gsdmd deletion prevents pyroptosis but also prevents IL-1β and IL-18 secretion; similarly, Casp8 deletion prevents cell extrinsic apoptosis, but may also trigger necroptosis, cause a lymphoproliferative disorder and inhibit innate immune receptor signalling
. Despite such difficulties, our understanding of programmed cell death has advanced considerably in recent years, revealing the utility of programmed cell death during infection both to destroy intracellular niches, and to coordinate an appropriate innate immune response thereafter. Finally, if a programmed cell death modality is exquisitely effective against a specific virulence strategy, this exerts strong selective pressure for those pathogens to evade the response. Therefore, when interpreting the results of experimental infections it is important to keep in mind the competing possibilities that the host may be benefiting, the pathogen may be evading, or host defence and pathogenic evasion may both be partially effective. In this regard, the identification of new infectious agents that fail to evade specific cell death pathways can aid our understanding of the true function of programmed cell death during infection. 
